SYRE vs. RXT
Compare and contrast key facts about Spyre Therapeutics Inc. (SYRE) and Rackspace Technology, Inc. (RXT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SYRE or RXT.
Correlation
The correlation between SYRE and RXT is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SYRE vs. RXT - Performance Comparison
Key characteristics
SYRE:
0.01
RXT:
0.83
SYRE:
0.52
RXT:
1.49
SYRE:
1.06
RXT:
1.19
SYRE:
0.01
RXT:
0.65
SYRE:
0.02
RXT:
3.34
SYRE:
34.84%
RXT:
18.23%
SYRE:
71.34%
RXT:
73.26%
SYRE:
-99.12%
RXT:
-95.86%
SYRE:
-92.43%
RXT:
-88.65%
Fundamentals
SYRE:
$1.34B
RXT:
$657.67M
SYRE:
-$37.90
RXT:
-$3.45
SYRE:
$0.00
RXT:
$2.05B
SYRE:
-$147.31M
RXT:
-$441.50M
Returns By Period
In the year-to-date period, SYRE achieves a -2.58% return, which is significantly lower than RXT's 33.94% return.
SYRE
-2.58%
9.04%
-14.58%
0.62%
-35.63%
N/A
RXT
33.94%
25.69%
33.94%
63.54%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SYRE vs. RXT — Risk-Adjusted Performance Rank
SYRE
RXT
SYRE vs. RXT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Spyre Therapeutics Inc. (SYRE) and Rackspace Technology, Inc. (RXT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SYRE vs. RXT - Dividend Comparison
Neither SYRE nor RXT has paid dividends to shareholders.
Drawdowns
SYRE vs. RXT - Drawdown Comparison
The maximum SYRE drawdown since its inception was -99.12%, roughly equal to the maximum RXT drawdown of -95.86%. Use the drawdown chart below to compare losses from any high point for SYRE and RXT. For additional features, visit the drawdowns tool.
Volatility
SYRE vs. RXT - Volatility Comparison
The current volatility for Spyre Therapeutics Inc. (SYRE) is 15.63%, while Rackspace Technology, Inc. (RXT) has a volatility of 19.19%. This indicates that SYRE experiences smaller price fluctuations and is considered to be less risky than RXT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SYRE vs. RXT - Financials Comparison
This section allows you to compare key financial metrics between Spyre Therapeutics Inc. and Rackspace Technology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities